Read + Share
Amedeo Smart
Independent Medical Education
Tang H, Lu Y, Okun MS, Donahoo WT, et al. Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population-Based Cohort Study. Mov Disord 2024 Aug 27. doi: 10.1002/mds.29992.PMID: 39189078
Email
LinkedIn
Privacy Policy